Navigation Links
Par Pharmaceutical Companies Reports First Quarter 2012 Results
Date:5/8/2012

WOODCLIFF LAKE, N.J., May 8, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the first quarter ended March 31, 2012.

For the first quarter ended March 31, 2012, the Company reported total revenues of $271.5 million and a loss from continuing operations of $28.7 million, or $0.79 per diluted share, which includes a $45 million charge related to the Company's best estimate of loss related to the potential settlement of the on-going Department of Justice investigation of Strativa's marketing of Megace® ES. On an adjusted cash basis (non-GAAP measure), which excludes the $45 million charge, a milestone payment, amortization expenses, other transaction-related costs and the impairment of an IPR&D asset, income from continuing operations was $29.8 million, or $0.80 per diluted share for the first quarter 2012.  (Refer to attached reconciliation table between GAAP and adjusted non-GAAP amounts.)

First Quarter Highlights  Key Product Sales (Net sales comparisons at the product level are to fourth quarter 2011.)

  • Metoprolol:  For the quarter ended March 31, 2012, net sales of metoprolol succinate were $61.8 million compared to $56.4 million in the fourth quarter 2011.  The increase was driven by customer buying patterns.  Par Pharmaceutical, the Company's generic drug division, is the authorized generic for all strengths of AstraZeneca's Toprol XL®.
  • Budesonide EC:  Net sales for budesonide EC in the first quarter 2012 were $38.0 million compared to $33.1 million in the fourth quarter 2011.  The increase was driven by customer buying patterns.  Par Pharmaceutical is the authorized generic for AstraZeneca's Entocort® EC.
  • Propafenone Hydrochloride ER: Net sales for propafenone hydrochloride ER in the first quarter were $19.1 m
    '/>"/>

    • SOURCE Par Pharmaceutical Companies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... May 22, 2013 Pomerantz Grossman ... claims on behalf of investors of Intuitive Surgical, Inc. ... ) (CUSIP: 46120E602) who purchased Intuitive Surgical common stock ... "Class Period"). Such investors are advised to contact ... or 888-476-6529, ext. 237. The investigation ...
    (Date:5/22/2013)... 2013 Hemoglobin A1C levels increased over ... 2 diabetes, while modest improvements in A1C control ... can lead to substantial healthcare cost savings, according ... for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual ... by Valeritas, makers of the V-Go ® ...
    (Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...
    Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
    ... YORK, Dec 1, 2011 Reportlinker.com announces that a new ... The Outlook for Medical Devices in Latin America ... Covered! Argentina Brazil ... Cuba Mexico Peru ...
    ... Fla., Dec. 1, 2011  Hybrid Fuels, Inc. (Pink Sheets: ... acquired 100% of the shares of EMG Marketing Solutions, ... sales, marketing and product development expertise to the multi-billion ... a wholly owned subsidiary of Hybrid Fuels. ...
    Cached Medicine Technology:The Outlook for Medical Devices in Latin America 2The Outlook for Medical Devices in Latin America 3The Outlook for Medical Devices in Latin America 4Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry 2
    (Date:5/22/2013)... Troy, NY (PRWEB) May 22, 2013 ... Sinai and Rensselaer Polytechnic Institute today announced an ... and development of new diagnostic tools and treatments ... in a signing ceremony on May 22, 2013. ... their expertise—Rensselaer’s in engineering and invention prototyping and ...
    (Date:5/22/2013)... (HealthDay News) -- Children and teens exposed to radiation ... develop cancer, according to a large, long-term study. ... of 10,000 young people who each had one CT ... to occur within 10 years, according to researchers from ... carefully weight the risks to patients when making decisions ...
    (Date:5/22/2013)... MA -- A typical pair of running shoes generates ... a 100-watt light bulb on for one week, according ... surprising to researchers isn,t the size of a shoe,s ... comes from. , The researchers found that more than ... from manufacturing processes, with a smaller percentage arising from ...
    (Date:5/22/2013)... CORVALLIS, Ore. Researchers have developed a new drug ... help treat lung cancer, and in laboratory and animal ... to other organs while significantly improving the treatment of ... extraordinarily small size of nanoparticles, existing cancer drugs, and ... of cancer cells to resist attack. , The combination ...
    (Date:5/22/2013)... TheBeautyPlace.com features Toppik and Bosley hair fibers, two hair loss ... or balding hair. Hair loss treatments can be a lengthy ... during this waiting period, one can use these hair loss ... hair transplant surgery in general. , Bosley and Toppik ... way to eliminate the appearance of balding and thinning hair. ...
    Breaking Medicine News(10 mins):Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:Footwear's (carbon) footprint 2Health News:Footwear's (carbon) footprint 3Health News:Footwear's (carbon) footprint 4Health News:Research offers promising new approach to treatment of lung cancer 2Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2
    ... Nevada,s,largest and most trusted medical imaging company celebrates ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050322/DRLOGO ) On ... in Desert,Radiologists and Las Vegas history by completing ... to the people of Southern,Nevada and beyond. ...
    ... WASHINGTON, Aug. 30 HHS Secretary Mike,Leavitt today ... $75,million to states, territories and four metropolitan areas ... pandemic influenza outbreak., "The additional funding will ... to continue planning, training and acquiring needed equipment,for ...
    ... The following was issued,today by Active Minds, Inc.: ... Active Minds, Inc. WHAT: Ms. Malmon is available ... including depression and suicide Ms. Malmon is a ... for her unique peer-to-peer approach in addressing,the mental health ...
    ... Received Compassionate Hospice Care Before Dying, Thailand,s Lop Buri ... Partner to Open, Free AIDS Treatment Center Providing Lifesaving Antiretroviral ... Ceremony Friday, ... August 31st at 9:30 am, LOP ...
    ... Honberg,director of policy and legal affairs for the National ... today,s Virginia Tech,Panel Report: "The report is important ... just in Virginia but throughout the country. Last ... in,a national survey. The national average also was ,D., ...
    ... ATSI ), manufacturer and marketer of state-of-the-art ... will present at the,2007 Thomas Weisel Partners Healthcare ... Company,s presentation is scheduled for Wednesday, September,5, 2007 ... and CEO of ATS,Medical, will present a review ...
    Cached Medicine News:Health News:Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas 2Health News:Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas 3Health News:HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness 2Health News:College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues 2Health News:Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri 2Health News:Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri 3Health News:Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri 4Health News:Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri 5Health News:Virginia Tech Report Has National Importance 2Health News:ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference 2
    ... Biotech Captia™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked ... detection and quantitative determination of IgG antibody ... specimens may be used for the determination ... convalescent, may be used to demonstrate seroconversion ...
    ELISA kit for Varicella-zoster IgM....
    ... Varicella-Zoster Virus (VZV) IgG Enzyme-Linked Immunosorbent Assay ... quantitative determination of IgG antibody to VZV ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
    ... Zeus Scientific, Inc. Mumps IgG ELISA test ... of Mumps IgG antibody in human serum. ... results of this test, together with other ... of immune status, and/or aid in the ...
    Medicine Products: